Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pemphigus | 5 | 2018 | 116 | 0.890 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 3 | 2018 | 209 | 0.760 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2022 | 115 | 0.750 |
Why?
|
Alopecia | 1 | 2022 | 414 | 0.570 |
Why?
|
Desmogleins | 1 | 2014 | 4 | 0.480 |
Why?
|
Carcinoma, Verrucous | 2 | 2024 | 27 | 0.450 |
Why?
|
Skin Neoplasms | 7 | 2024 | 5796 | 0.400 |
Why?
|
Neutrophils | 1 | 2022 | 3767 | 0.320 |
Why?
|
Sezary Syndrome | 2 | 2017 | 77 | 0.280 |
Why?
|
Mycosis Fungoides | 2 | 2017 | 167 | 0.260 |
Why?
|
Autoantibodies | 1 | 2014 | 2116 | 0.250 |
Why?
|
Uveal Neoplasms | 1 | 2024 | 339 | 0.190 |
Why?
|
Oral Hemorrhage | 1 | 2018 | 24 | 0.160 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15815 | 0.160 |
Why?
|
Blister | 1 | 2018 | 87 | 0.150 |
Why?
|
Aminolevulinic Acid | 1 | 2018 | 142 | 0.140 |
Why?
|
Mouth Diseases | 1 | 2018 | 238 | 0.130 |
Why?
|
Iran | 2 | 2014 | 733 | 0.110 |
Why?
|
Oral Surgical Procedures | 1 | 2016 | 166 | 0.110 |
Why?
|
Photosensitizing Agents | 1 | 2018 | 608 | 0.110 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2014 | 85 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2017 | 772 | 0.100 |
Why?
|
Photochemotherapy | 1 | 2018 | 808 | 0.100 |
Why?
|
Adnexal Diseases | 1 | 2013 | 104 | 0.100 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2017 | 707 | 0.090 |
Why?
|
Observer Variation | 2 | 2014 | 2596 | 0.090 |
Why?
|
Sarcoma, Kaposi | 1 | 2013 | 376 | 0.090 |
Why?
|
Skin | 2 | 2016 | 4467 | 0.090 |
Why?
|
Miconazole | 1 | 2009 | 9 | 0.090 |
Why?
|
Area Under Curve | 1 | 2014 | 1634 | 0.080 |
Why?
|
Urinary Bladder, Neurogenic | 1 | 2011 | 174 | 0.080 |
Why?
|
Dermatomycoses | 1 | 2009 | 48 | 0.080 |
Why?
|
Wounds, Nonpenetrating | 1 | 2016 | 795 | 0.080 |
Why?
|
Immunoconjugates | 1 | 2017 | 947 | 0.080 |
Why?
|
Congenital Abnormalities | 2 | 2011 | 704 | 0.080 |
Why?
|
Radiotherapy | 1 | 2016 | 1503 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11058 | 0.070 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2011 | 438 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 1 | 2012 | 559 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 3804 | 0.070 |
Why?
|
Urinary Incontinence | 1 | 2011 | 495 | 0.070 |
Why?
|
Paclitaxel | 1 | 2013 | 1715 | 0.070 |
Why?
|
Melanoma | 1 | 2024 | 5692 | 0.060 |
Why?
|
Chromatin | 1 | 2017 | 2939 | 0.060 |
Why?
|
Abnormalities, Multiple | 3 | 2024 | 1415 | 0.060 |
Why?
|
Thiophenes | 1 | 2009 | 587 | 0.060 |
Why?
|
Darier Disease | 1 | 2024 | 13 | 0.060 |
Why?
|
Epigenesis, Genetic | 1 | 2018 | 3754 | 0.060 |
Why?
|
Antifungal Agents | 1 | 2009 | 745 | 0.060 |
Why?
|
Urinary Tract Infections | 1 | 2011 | 816 | 0.060 |
Why?
|
Burns | 1 | 2016 | 1864 | 0.060 |
Why?
|
Eyebrows | 1 | 2024 | 35 | 0.060 |
Why?
|
Neurosurgery | 1 | 2010 | 669 | 0.060 |
Why?
|
Linear Models | 1 | 2014 | 5876 | 0.060 |
Why?
|
Imidazoles | 1 | 2009 | 1175 | 0.050 |
Why?
|
Spinal Cord | 1 | 2010 | 1815 | 0.050 |
Why?
|
Apoptosis | 1 | 2018 | 9492 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2014 | 2250 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8491 | 0.050 |
Why?
|
Sacrococcygeal Region | 2 | 2011 | 53 | 0.050 |
Why?
|
Male | 13 | 2024 | 358719 | 0.050 |
Why?
|
Meningocele | 2 | 2011 | 46 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2018 | 25860 | 0.050 |
Why?
|
Humans | 18 | 2024 | 759255 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12152 | 0.040 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2024 | 634 | 0.040 |
Why?
|
Aged | 5 | 2022 | 168617 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20031 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21336 | 0.040 |
Why?
|
Prednisolone | 1 | 2018 | 328 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2010 | 3526 | 0.030 |
Why?
|
Mouth Mucosa | 1 | 2018 | 426 | 0.030 |
Why?
|
Middle Aged | 7 | 2024 | 219653 | 0.030 |
Why?
|
Young Adult | 3 | 2018 | 58483 | 0.030 |
Why?
|
Adult | 8 | 2018 | 219390 | 0.030 |
Why?
|
Lacerations | 1 | 2016 | 149 | 0.030 |
Why?
|
Female | 11 | 2024 | 390240 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2017 | 13621 | 0.030 |
Why?
|
Adolescent | 4 | 2018 | 87560 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 24049 | 0.030 |
Why?
|
Methotrexate | 1 | 2018 | 1714 | 0.020 |
Why?
|
Epigenomics | 1 | 2017 | 935 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3275 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2017 | 2698 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1799 | 0.020 |
Why?
|
Urologic Diseases | 1 | 2010 | 247 | 0.020 |
Why?
|
Neurologic Examination | 1 | 2010 | 916 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2018 | 58867 | 0.020 |
Why?
|
Transcription Factors | 1 | 2024 | 12106 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12774 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2010 | 1190 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 4168 | 0.010 |
Why?
|
Biopsy | 1 | 2012 | 6772 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2011 | 26109 | 0.010 |
Why?
|
Pilot Projects | 1 | 2013 | 8540 | 0.010 |
Why?
|
Infant | 2 | 2011 | 35941 | 0.010 |
Why?
|
Retrospective Studies | 3 | 2012 | 80121 | 0.010 |
Why?
|
Child, Preschool | 2 | 2011 | 41935 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15264 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2011 | 12964 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11476 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12386 | 0.010 |
Why?
|
Child | 2 | 2011 | 79623 | 0.010 |
Why?
|
Cohort Studies | 1 | 2013 | 41247 | 0.010 |
Why?
|
Risk Factors | 1 | 2010 | 74167 | 0.000 |
Why?
|
United States | 1 | 2011 | 72237 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2009 | 64879 | 0.000 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_